Clinical Coagulation, Malmö

531 – 540 of 659

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1000575?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
53
54
55
56
…
66
next »

2006
Mark The next generation of hemophilia treatment specialists
Berntorp, Erik ^LU ; Gomperts, Edward ; Hoots, Keith and Wong, Wing-Yen (2006) In Seminars in Thrombosis and Hemostasis 32. p.39-42
- Contribution to journal › Article
Mark Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3.
Berntorp, Erik ^LU (2006) In Seminars in Thrombosis and Hemostasis 32(6). p.621-625
- Contribution to journal › Article
2005
Mark Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo.
Larsson, Jonas ^LU ; Blank Savukinas, Ulrika ^LU ; Klintman, Jenny ^LU ; Magnusson, Mattias ^LU and Karlsson, Stefan ^LU (2005) In Experimental Hematology 33(5). p.592-596
- Contribution to journal › Article
Mark Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee.
Björkman, Anders ^LU ; Björkman-Burtscher, Isabella ^LU ; Svensson, Peter ^LU ; Hillarp, Andreas ^LU ; Besjakov, Jack ^LU and Benoni, Göran ^LU (2005) In Archives of Orthopaedic and Trauma Surgery 125(1). p.51-55
- Contribution to journal › Article
Mark Recurrence Rate After a First Venous Thrombosis in Patients With Familial Thrombophilia.
Vossen, Carla Y ; Walker, Isobel D ; Svensson, Peter ^LU ; Souto, Juan C ; Scharrer, Inge ; Preston, F Eric ; Palareti, Gualtiero ; Pabinger, Ingrid ; van der Meer, Felix J M and Makris, Mike , et al. (2005) In Arteriosclerosis, Thrombosis and Vascular Biology 25. p.1992-1997
- Contribution to journal › Article
Mark Pharmacokinetic studies on Wilfactin((R)), a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods
Goudemand, J ; Scharrer, I ; Berntorp, Erik ^LU ; Lee, CA ; Borel-Derlon, A ; Stieltjes, N ; Caron, C ; Scherrmann, JM ; Bridey, F and Tellier, Z , et al. (2005) In Journal of Thrombosis and Haemostasis 3(10). p.2219-2227
- Contribution to journal › Article
Mark Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency of a certain disease haplotype.
Lanke, Elsa ^LU ; Johansson, Anna ^LU ; Halldén, Christer ^LU and Lethagen, Stefan ^LU (2005) In Journal of Thrombosis and Haemostasis 3(12). p.2656-2663
- Contribution to journal › Article
Mark APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.
Strandberg, Karin ^LU ; Stenflo, Johan ^LU ; Nilsson, C and Svensson, Peter ^LU (2005) In Journal of Thrombosis and Haemostasis 3(11). p.2578-2580
- Contribution to journal › Letter
Mark Cost effectiveness of haemophilia treatment: a cross-national assessment.
Lippert, Barbara ; Berger, Karin ; Berntorp, Erik ^LU ; Giangrande, Paul ; van den Berg, Marijke ; Schramm, Wolfgang and Siebert, Uwe (2005) In Blood Coagulation and Fibrinolysis 16(7). p.477-485
- Contribution to journal › Article
Mark Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Donfield, S M ; Nelson, G W ; Oldenburg, J ; Shapiro, A D ; Dimichele, D M ; Ewenstein, B M ; Gomperts, E D and Winkler, C A (2005) In Haemophilia 11(4). p.427-429
- Contribution to journal › Letter

« previous
1
…
53
54
55
56
…
66
next »